| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2016 | 2017 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.500 | None | 0.955 | 0 | 0 | 2002 | 2018 | ||||||||
|
Janus kinase 3 | 0.505 | 0.731 | 5.9E-06 |
|
disease | 0.460 | None | 1.000 | 0 | 0 | 2006 | 2011 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.964 | 0 | 0 | 1996 | 2019 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.570 | None | 0.857 | 0 | 0 | 2000 | 2019 | ||||||||
|
RAD54 like | 0.633 | 0.423 | 2.4E-15 |
|
disease | 0.600 | None | 0 | 0 | |||||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2011 | 2018 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2003 | 2003 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.923 | 0 | 0 | 1993 | 2018 | ||||||||
|
folliculin | 0.537 | 0.885 | 0.79 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.350 | None | 1.000 | 0 | 0 | 1995 | 2016 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.500 | None | 0 | 0 | |||||||||||
|
mutL homolog 3 | 0.582 | 0.538 | 4.9E-08 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2010 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 1995 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 1993 | 2017 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.400 | None | 0.950 | 0 | 0 | 1993 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 1999 | 1999 |